ArticleCureus2022
The Role of Diffusion Tensor Tractography in Assessment of Spondylotic Myelopathy.
Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 3 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Cervical spondylotic myelopathy (CSM) describes a neurological deficit related to the spinal cord due to the changes in the facet joints and discs of the cervical spine as a result of degeneration. Diagnosis is mainly dependent on imaging. Diffusion tensor tractography (DTT), being a non-invasive technique, shows better sensitivity when compared to the conventional T2WI sequence in the early detection of cervical spondylotic myelopathy (CSM). The objective was to determine the diagnostic accuracy of the apparent diffusion coefficient (ADC) in predicting high T2 signals in CSM. Methods A prospective observational study was done on 47 subjects aged between 25 and 70 years, referred to the department of radiology with clinical and imaging evidence of CSM in a tertiary care institute in Chennai. Nurick classification system was used to assess severity clinically. Diffusion-weighted imaging and DTT were done with 1.5 Tesla MRI. The primary outcome variable was a high T2 signal. Mean fractional anisotropy (FA) at the stenotic level and ADC value at a stenotic level were considered explanatory variables. The sensitivity, specificity, predictive values, and diagnostic accuracy of the screening test with the decided cut-off values along with their 95% CI were presented. P-value <0.05 was considered statistically significant. SPSS version 22 (IBM Inc., Armonk, New York) was used for statistical analysis. Results The mean age was 48.26 ± 10.28 years. The majority (72.34%) were males, the majority (42.55%) had a Nurick score of two, and 25.53% had a Nurick score of one. Twenty-six (55.32%) reported a high T2 signal, 36 (76.60%) had elevated ADC, and 11 (23.40 %) had no elevated ADC. There was a statistically significant difference in mean FA and ADC values across groups categorized as non-stenotic level and stenotic level (p-value <0.05). The ADC value had a moderately high sensitivity (76.92%) and low specificity (23.81%) in predicting high T2 signals with a diagnostic accuracy of 53.19%. Conclusion DTI parameters at stenotic level (ADC and FA values) in patients with cervical spondylosis help in the early detection of cervical cord compressive myelopathy prior to the appearance of T2 signal changes in conventional MRI, thereby improving clinical outcome and patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.